Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$237K Buy
861
+32
+4% +$9.04K 0.02% 391
2026
Q1
$234K Sell
829
-589
-42% -$163K 0.02% 376
2025
Q4
$390K Buy
1,418
+321
+29% +$90K 0.03% 302
2025
Q3
$316K Buy
1,097
+89
+9% +$26.3K 0.03% 320
2025
Q2
$333K Buy
1,008
+34
+3% +$11K 0.03% 306
2025
Q1
$320K Sell
974
-1,708
-64% -$515K 0.04% 295
2024
Q4
$741K Sell
2,682
-3,495
-57% -$1.11M 0.08% 210
2024
Q3
$2.14M Sell
6,177
-107
-2% -$36.8K 0.28% 88
2024
Q2
$2.08M Buy
6,284
+221
+4% +$76.2K 0.28% 87
2024
Q1
$2.2M Sell
6,063
-73
-1% -$24K 0.3% 85
2023
Q4
$1.84M Sell
6,136
-2,090
-25% -$611K 0.28% 96
2023
Q3
$2.35M Sell
8,226
-162
-2% -$46.2K 0.36% 81
2023
Q2
$2.35M Sell
8,388
-64
-0.8% -$16.7K 0.35% 81
2023
Q1
$2.16M Buy
+8,452
New +$2.46M 0.34% 82

Other funds holding CI

Nilsine Partners's CI Position: Q2 2026 in Review

Nilsine Partners increased its Cigna (CI) stake by 3.9% in Q2 2026, buying an estimated $9.04K and bringing the position to 861 shares worth $237K. The position accounts for 0.02% of the portfolio, ranked #391.

Nilsine Partners first reported a position in CI in Q1 2023 and has held it in 14 quarters since. The position peaked at $2.35M in Q2 2023. 476 funds tracked by Wall St. Rank hold CI as of Q2 2026.

  • Nilsine Partners held 861 shares of Cigna worth $237K as of Q2 2026.
  • Nilsine Partners bought 32 Cigna shares in Q2 2026, an estimated $9.04K.
  • Cigna made up 0.02% of Nilsine Partners's portfolio in Q2 2026, its #391 holding.
  • Nilsine Partners first reported a position in Cigna in Q1 2023 and has held it in 14 quarters since.
  • Nilsine Partners's Cigna position peaked at $2.35M in Q2 2023.
  • 476 funds tracked by Wall St. Rank held Cigna as of Q2 2026.

Based on Nilsine Partners's 13F filing for Q2 2026, filed 24 Jul 2026.